The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Companion Diagnostic Technologies-Global Market Insights and Sales Trends 2025

Companion Diagnostic Technologies-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1820181

No of Pages : 100

Ask Your Query

Report Description
Table of Content

Synopsis
Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.

The global Companion Diagnostic Technologies market size is expected to reach US$ 6057.7 million by 2029, growing at a CAGR of 11.3% from 2023 to 2029. The market is mainly driven by the significant applications of Companion Diagnostic Technologies in various end use industries. The expanding demands from the Oncology, Cardiovascular, Central Nervous System and Auto immune & Inflammation, are propelling Companion Diagnostic Technologies market. Immunohistochemistry, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Molecular Diagnostics segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Companion Diagnostic Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Companion Diagnostic Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Companion Diagnostic Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Companion Diagnostic Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Companion Diagnostic Technologies covered in this report include Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories, Thermo Fisher Scientific, bioMerieux, Myriad Genetics, Resonance Health Ltd. and Leica Microsystems, etc.
The global Companion Diagnostic Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories
Thermo Fisher Scientific
bioMerieux
Myriad Genetics
Resonance Health Ltd.
Leica Microsystems
Danaher

Global Companion Diagnostic Technologies market, by region:

North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Companion Diagnostic Technologies market, Segment by Type:

Immunohistochemistry
Molecular Diagnostics

Global Companion Diagnostic Technologies market, by Application

Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Companion Diagnostic Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Companion Diagnostic Technologies
1.1 Companion Diagnostic Technologies Market Overview
1.1.1 Companion Diagnostic Technologies Product Scope
1.1.2 Companion Diagnostic Technologies Market Status and Outlook
1.2 Global Companion Diagnostic Technologies Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Companion Diagnostic Technologies Market Size by Region (2018-2029)
1.4 Global Companion Diagnostic Technologies Historic Market Size by Region (2018-2023)
1.5 Global Companion Diagnostic Technologies Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Companion Diagnostic Technologies Market Size (2018-2029)
1.6.1 North America Companion Diagnostic Technologies Market Size (2018-2029)
1.6.2 Europe Companion Diagnostic Technologies Market Size (2018-2029)
1.6.3 Asia-Pacific Companion Diagnostic Technologies Market Size (2018-2029)
1.6.4 Latin America Companion Diagnostic Technologies Market Size (2018-2029)
1.6.5 Middle East & Africa Companion Diagnostic Technologies Market Size (2018-2029)
2 Companion Diagnostic Technologies Market by Type
2.1 Introduction
2.1.1 Immunohistochemistry
2.1.2 Molecular Diagnostics
2.2 Global Companion Diagnostic Technologies Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Companion Diagnostic Technologies Historic Market Size by Type (2018-2023)
2.2.2 Global Companion Diagnostic Technologies Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Companion Diagnostic Technologies Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Companion Diagnostic Technologies Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Companion Diagnostic Technologies Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Companion Diagnostic Technologies Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Companion Diagnostic Technologies Revenue Breakdown by Type (2018-2029)
3 Companion Diagnostic Technologies Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Cardiovascular
3.1.3 Central Nervous System
3.1.4 Auto immune & Inflammation
3.1.5 Virology
3.1.6 Others
3.2 Global Companion Diagnostic Technologies Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Companion Diagnostic Technologies Historic Market Size by Application (2018-2023)
3.2.2 Global Companion Diagnostic Technologies Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Companion Diagnostic Technologies Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Companion Diagnostic Technologies Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Companion Diagnostic Technologies Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Companion Diagnostic Technologies Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Companion Diagnostic Technologies Revenue Breakdown by Application (2018-2029)
4 Companion Diagnostic Technologies Competition Analysis by Players
4.1 Global Companion Diagnostic Technologies Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Companion Diagnostic Technologies as of 2022)
4.3 Date of Key Players Enter into Companion Diagnostic Technologies Market
4.4 Global Top Players Companion Diagnostic Technologies Headquarters and Area Served
4.5 Key Players Companion Diagnostic Technologies Product Solution and Service
4.6 Competitive Status
4.6.1 Companion Diagnostic Technologies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Dako (Agilent Technologies)
5.1.1 Dako (Agilent Technologies) Profile
5.1.2 Dako (Agilent Technologies) Main Business
5.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Products, Services and Solutions
5.1.4 Dako (Agilent Technologies) Companion Diagnostic Technologies Revenue (US$ Million) & (2018-2023)
5.1.5 Dako (Agilent Technologies) Recent Developments
5.2 Qiagen
5.2.1 Qiagen Profile
5.2.2 Qiagen Main Business
5.2.3 Qiagen Companion Diagnostic Technologies Products, Services and Solutions
5.2.4 Qiagen Companion Diagnostic Technologies Revenue (US$ Million) & (2018-2023)
5.2.5 Qiagen Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Companion Diagnostic Technologies Products, Services and Solutions
5.3.4 Roche Companion Diagnostic Technologies Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Laboratories Recent Developments
5.4 Abbott Laboratories
5.4.1 Abbott Laboratories Profile
5.4.2 Abbott Laboratories Main Business
5.4.3 Abbott Laboratories Companion Diagnostic Technologies Products, Services and Solutions
5.4.4 Abbott Laboratories Companion Diagnostic Technologies Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Laboratories Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Products, Services and Solutions
5.5.4 Thermo Fisher Scientific Companion Diagnostic Technologies Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 bioMerieux
5.6.1 bioMerieux Profile
5.6.2 bioMerieux Main Business
5.6.3 bioMerieux Companion Diagnostic Technologies Products, Services and Solutions
5.6.4 bioMerieux Companion Diagnostic Technologies Revenue (US$ Million) & (2018-2023)
5.6.5 bioMerieux Recent Developments
5.7 Myriad Genetics
5.7.1 Myriad Genetics Profile
5.7.2 Myriad Genetics Main Business
5.7.3 Myriad Genetics Companion Diagnostic Technologies Products, Services and Solutions
5.7.4 Myriad Genetics Companion Diagnostic Technologies Revenue (US$ Million) & (2018-2023)
5.7.5 Myriad Genetics Recent Developments
5.8 Resonance Health Ltd.
5.8.1 Resonance Health Ltd. Profile
5.8.2 Resonance Health Ltd. Main Business
5.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Products, Services and Solutions
5.8.4 Resonance Health Ltd. Companion Diagnostic Technologies Revenue (US$ Million) & (2018-2023)
5.8.5 Resonance Health Ltd. Recent Developments
5.9 Leica Microsystems
5.9.1 Leica Microsystems Profile
5.9.2 Leica Microsystems Main Business
5.9.3 Leica Microsystems Companion Diagnostic Technologies Products, Services and Solutions
5.9.4 Leica Microsystems Companion Diagnostic Technologies Revenue (US$ Million) & (2018-2023)
5.9.5 Leica Microsystems Recent Developments
5.10 Danaher
5.10.1 Danaher Profile
5.10.2 Danaher Main Business
5.10.3 Danaher Companion Diagnostic Technologies Products, Services and Solutions
5.10.4 Danaher Companion Diagnostic Technologies Revenue (US$ Million) & (2018-2023)
5.10.5 Danaher Recent Developments
6 North America
6.1 North America Companion Diagnostic Technologies Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Companion Diagnostic Technologies Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Companion Diagnostic Technologies Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Companion Diagnostic Technologies Market Dynamics
11.1 Companion Diagnostic Technologies Industry Trends
11.2 Companion Diagnostic Technologies Market Drivers
11.3 Companion Diagnostic Technologies Market Challenges
11.4 Companion Diagnostic Technologies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}